Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation

Transplantation

Volumn 77, Issue 8, 2004, Pages 1209-1214

  Tzakis, Andreas G ^a   Tryphonopoulos, Panagiotis ^a   Kato, Tomoaki ^a   Nishida, Seigo ^a   Levi, David M ^a   Madariaga, Juan R ^a   Gaynor, Jeffrey J ^a   De Faria, Werviston ^a   Regev, Arie ^a   Esquenazi, Violet ^a   Weppler, Debbie ^a   Ruiz, Phillip ^a,b   Miller, Joshua ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b JACKSON MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; CORTICOSTEROID; COTRIMOXAZOLE; CREATININE; CYCLOSPORIN A; CYTOMEGALOVIRUS ANTIBODY; DAPSONE; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; OKT 3; RAPAMYCIN; TACROLIMUS;

ADULT; ALLOGRAFT; ARTICLE; CADAVER DONOR; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; FEMALE; FEVER; GRAFT REJECTION; HERPES ZOSTER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; LIVER TRANSPLANTATION; MALE; NEPHROTOXICITY; ORGAN TRANSPLANTATION; PNEUMOCYSTIS PNEUMONIA; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RASH; SKIN CANCER; STEROID THERAPY; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 2342582720     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000116562.15920.43     Document Type: Article

References (15)

1. Calne R, Friend P, Moffatt S, et al. Prope tolerance, perioperative Campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet 1998; 351(9117): 1701-1702.
2. Calne R, Moffatt SD, Friend PJ, et al. Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients. Transplantation 1999; 68(10): 1613-1616.
3. Stuart FP, Leventhal JR, Kaufman DB, et al. Alemtuzumab facilitates prednisone free immunosuppression in kidney transplant recipients with no early rejection. Am J Transplant 2002; 2(S3): 397.
4. Knechtle SJ, Pirsch JD, H Fechner J, et al. Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. Am J Transplant 2003; 3(6): 722-730.
5. Tzakis AG, Kato T, Nishida S, et al. Campath 1H combined with tacrolimus in intestinal and multivisceral transplantation. Transplantation 2003; 75(9): 1512-1517.
6. Demetris AJ, Batts KP, Dhillon AP, et al. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997; 25(3): 658-663.
7. Tzakis AG. Cytomegalovirus prophylaxis with ganciclovir and cytomegalovirus immune globulin in liver and intestinal transplantation. Transpl Infect Dis 2001; 3(S2): 35.
8. Greig P, Lilly L, Scudamore C, et al. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporine A trial: 1 year follow-up. Liver Transpl 2003; 9(6): 587-595.
9. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349(10): 931-940.
10. Raimondo ML, Dagher L, Papatheodoridis GV, et al. Long term mycophenolate mofetil monotherapy in combination with calcineurin inhibitors for chronic renal dysfunction after liver transplantation. Transplantation 2003; 75(2): 186-190.
11. MacDonald AS. A worldwide phase III randomized, controlled safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts. Transplantation 2001; 71(2): 271-280.
12. McAlister VC, Gao Z, Peltekian K, et al. Sirolimus-tacrolimus combination immunosuppression. Lancet 2000; 355: 376-377.
13. Groth CG, Backman L, Morales JM, et al. Sirolimus (rapamycin) based therapy in human renal transplantation. Transplantation 1999; 67(7): 1036-1042.
14. Kahan BD. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomized multicentre study. Lancet 2000; 356: 194-202.
15. Starzl TE, Murase N, Abu-Elmagd K, et al. Tolerogenic immunosuppression for organ transplantation. Lancet 2003; 361: 1502-1510.